Table 3.
Postmatching: Change in Lipid Levels and Goal Attainment Among Statin Users in Statin Benefit Group 1
| Low-density lipoprotein cholesterol | High-intensity statin initiators (N = 16,793) | Low-/moderate-intensity statin initiators (N = 16,964) | P value |
|---|---|---|---|
| Patients with ≥1 laboratory results during baseline, N (%) | 2586 (15.4) | 2918 (17.2) | <.001 |
| Most recent baseline (preinitiation) laboratory result (mg/dL) mean (SD) | 119.1 (42.04) | 123.7 (37.01) | <.001 |
| Patients with LDL-C <100 mg/dL at most recent baseline laboratory result, N (%) | 904 (35.0) | 770 (26.4) | <.001 |
| Patients with ≥1 laboratory results during 1-year follow-up, N (%) | 4031 (24.0) | 4271 (25.2) | .012 |
| Most recent follow-up laboratory result (mg/dL), mean (SD) | 79.3 (34.11) | 88.1 (31.78) | <.001 |
| Patients with LDL-C <100 mg/dL at 1-year follow-up, N (%) | 3222 (79.9) | 2999 (70.2) | <.001 |
| Patients with ≥1 laboratory results during baseline and 1-year follow-up, N (%) | 1668 (9.9) | 1878 (11.1) | .001 |
| Relative change in levels from baseline to 1-year follow-up, mean (SD), % | –25 (34) | –24 (29) | .472 |
LDL-C indicates low-density lipoprotein cholesterol; SD, standard deviation.